Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board moves to start rulemaking to revise pharmacy fees after DCA audit
Summary
After a Department of Consumer Affairs analysis showing a structural fund shortfall, the California State Board of Pharmacy voted to initiate rulemaking to amend fee rules in CCR §17.49. Staff said proposed fee changes would add about $6.25 million in revenue and include a $4.25 million allowance for unanticipated costs.
The California State Board of Pharmacy voted on March 18 to begin rulemaking to update its fee schedule (California Code of Regulations, title 16, section 17.49) after a Department of Consumer Affairs financial review found the board’s fund is running a structural deficit.
Matt Nishamini, a senior fiscal adviser at DCA, told the board the agency used a driver‑based cost model to map direct and indirect workload costs and forecasted unanticipated costs of about $4,250,000 beginning in fiscal 2026–27. He said proposed fee adjustments would produce roughly $6.25 million in additional annual revenue — including about $4.87 million from renewal fees — which would restore reserve months and cover projected increases in…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
